Abnormalities of neural circuitry in Alzheimer's disease - Hippocampus and cortical cholinergic innervation

被引:139
作者
Geula, C
机构
[1] Beth Israel Deaconess Med Ctr, Lab Neurodegenerat & Aging Res, Sect Gerontol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
D O I
10.1212/WNL.51.1_Suppl_1.S18
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Severe pathology in Alzheimer's disease (AD) results in marked disruption of cortical circuitry. Formation of neurofibrillary tangles, neuronal loss, decrease in dendritic extent, and synaptic depletion combine to halt communication among various cortical areas, resulting in anatomic isolation and fragmentation of many cortical zones. The clinical manifestation of this disruption is severe and debilitating cognitive dysfunction, often accompanied by psychiatric and behavioral disturbances and a diminished ability to perform activities of daily living. However, different cortical circuits are not equally vulnerable to AD pathology. In particular, two cortical systems that appear to be involved in the neural processing of memory are selectively vulnerable to degeneration in AD. One consists of connections between the hippocampus and its neighboring cortical structures within the temporal lobe. The second is the cortical cholinergic system that originates in neurons within the basal forebrain and innervates the entire cortical mantle. The circuitry in these systems shows early and severe degenerative changes in the course of AD. The selective vulnerability of these circuits is the probable reason for the early and marked loss of memory observed in these patients. This review presents current knowledge of the general pattern of cortical circuitry, followed by a summary of abnormalities of this circuitry in AD. The cortical circuits that exhibit selective pathology in AD are described in greater detail. Therapeutic implications of the abnormal circuitry in AD are also discussed. For therapies to be effective, early diagnosis of AD is necessary. Future efforts at AD therapy must be combined with an equally intense effort to develop tools capable of early diagnosis of AD, preferably at a preclinical stage before the onset of cognitive symptoms.
引用
收藏
页码:S18 / S29
页数:12
相关论文
共 108 条
  • [1] EFFECTS OF SCOPOLAMINE AND PHYSOSTIGMINE ON RECOGNITION MEMORY IN MONKEYS WITH IBOTENIC-ACID LESIONS OF THE NUCLEUS BASALIS OF MEYNERT
    AIGNER, TG
    MITCHELL, SJ
    AGGLETON, JP
    DELONG, MR
    STRUBLE, RG
    PRICE, DL
    WENK, GL
    MISHKIN, M
    [J]. PSYCHOPHARMACOLOGY, 1987, 92 (03) : 292 - 300
  • [2] Alzheimer A., 1977, Neurological Classics in Modern Translation, P41
  • [3] AMBERLA K, 1993, ACTA NEUROL SCAND, V88, P55
  • [4] The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease
    Arnold, Steven E.
    Hyman, Bradley T.
    Flory, Jill
    Damasio, Antonio R.
    Van Hoesen, Gary W.
    [J]. CEREBRAL CORTEX, 1991, 1 (01) : 103 - 116
  • [5] NEUROFIBRILLARY TANGLES BUT NOT SENILE PLAQUES PARALLEL DURATION AND SEVERITY OF ALZHEIMERS-DISEASE
    ARRIAGADA, PV
    GROWDON, JH
    HEDLEYWHYTE, ET
    HYMAN, BT
    [J]. NEUROLOGY, 1992, 42 (03) : 631 - 639
  • [6] DISTRIBUTION OF ALZHEIMER-TYPE PATHOLOGICAL-CHANGES IN NONDEMENTED ELDERLY INDIVIDUALS MATCHES THE PATTERN IN ALZHEIMERS-DISEASE
    ARRIAGADA, PV
    MARZLOFF, K
    HYMAN, BT
    [J]. NEUROLOGY, 1992, 42 (09) : 1681 - 1688
  • [7] BAYLIS GC, 1994, EXP BRAIN RES, V98, P110
  • [8] Double-blind placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease
    Becker, RE
    Colliver, JA
    Markwell, SJ
    Moriearty, PL
    Unni, LK
    Vicari, S
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 (03) : 124 - 131
  • [9] NEUROPATHOLOGICAL INDEXES OF ALZHEIMERS-DISEASE IN DEMENTED AND NONDEMENTED PERSONS AGED 80 YEARS AND OLDER
    BERG, L
    MCKEEL, DW
    MILLER, JP
    BATY, J
    MORRIS, JC
    [J]. ARCHIVES OF NEUROLOGY, 1993, 50 (04) : 349 - 358
  • [10] BERGERSWEENEY J, 1994, J NEUROSCI, V14, P4507